Literature DB >> 18086432

Cataracts in congenital toxoplasmosis.

Veena Arun1, A Gwendolyn Noble, Paul Latkany, Robert N Troia, Jessica Jalbrzikowski, Kristen Kasza, Ted Karrison, Simone Cezar, Mari Sautter, Mark J Greenwald, William Mieler, Marilyn B Mets, Ambereen Alam, Kenneth Boyer, Charles N Swisher, Nancy Roizen, Peter Rabiah, Monte A Del Monte, Rima McLeod.   

Abstract

PURPOSE: To determine the incidence and natural history of cataracts in children with congenital toxoplasmosis.
METHODS: Children referred to the National Collaborative Chicago-based Congenital Toxoplasmosis Study (NCCCTS) between 1981 and 2005 were examined by ophthalmologists at predetermined times according to a specific protocol. The clinical course and treatment of patients who developed cataracts were reviewed.
RESULTS: In the first year of life, 134 of 173 children examined were treated with pyrimethamine, sulfadiazine, and leukovorin, while the remaining 39 were not treated. Cataracts occurred in 27 eyes of 20 patients (11.6%, 95% confidence interval [7.2%, 17.3%]). Fourteen cataracts were present at birth and 13 developed postnatally. Locations of the cataracts included anterior polar (three eyes), anterior subcapsular (six eyes), nuclear (five eyes), posterior subcapsular (seven eyes), and unknown (six eyes). Thirteen cataracts were partial, nine total, and five with unknown complexity. Twelve cataracts remained stable, 12 progressed, and progression was not known for 3. Five of 27 eyes had cataract surgery, with 2 of these developing glaucoma. Sixteen eyes of 11 patients had retinal detachment and cataract. All eyes with cataracts had additional ocular lesions.
CONCLUSIONS: In the NCCCTS cohort, 11.6% of patients were diagnosed with cataracts. There was considerable variability in the presentation, morphology, and progression of the cataracts. Associated intraocular pathology was an important cause of morbidity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086432      PMCID: PMC2194289          DOI: 10.1016/j.jaapos.2007.03.017

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  15 in total

1.  Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens.

Authors:  Sogo Nishimoto; Kohki Kawane; Rie Watanabe-Fukunaga; Hidehiro Fukuyama; Yoshiyuki Ohsawa; Yasuo Uchiyama; Noriyasu Hashida; Nobuyuki Ohguro; Yasuo Tano; Takeshi Morimoto; Yutaka Fukuda; Shigekazu Nagata
Journal:  Nature       Date:  2003-08-28       Impact factor: 49.962

2.  Reactivations of ocular toxoplasmosis after cataract extraction.

Authors:  Lotje H Bosch-Driessen; Marjolijn B Plaisier; Jan S Stilma; Allegonda Van der Lelij; Aniki Rothova
Journal:  Ophthalmology       Date:  2002-01       Impact factor: 12.079

3.  Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.

Authors:  Nancy Roizen; Kristen Kasza; Theodore Karrison; Marilyn Mets; A Gwendolyn Noble; Kenneth Boyer; Charles Swisher; Paul Meier; Jack Remington; Jessica Jalbrzikowski; Rima McLeod; Michael Kipp; Peter Rabiah; Diana Chamot; Randee Estes; Simone Cezar; Douglas Mack; Linda Pfiffner; Mark Stein; Barbara Danis; Dushyant Patel; Joyce Hopkins; Ellen Holfels; Lazlo Stein; Shawn Withers; Audrey Cameron; Jeanne Perkins; Peter Heydemann
Journal:  Pediatrics       Date:  2006-07-24       Impact factor: 7.124

4.  Results of 20-year follow-up of congenital toxoplasmosis.

Authors:  J G Koppe; D H Loewer-Sieger; H de Roever-Bonnet
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

5.  Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.

Authors:  Antoine P Brézin; Philippe Thulliez; Jacques Couvreur; Roberto Nobré; Rima Mcleod; Marilyn B Mets
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

6.  Clinicopathological features of a congenital murine model of ocular toxoplasmosis.

Authors:  G N Dutton; J Hay; D M Hair; J Ralston
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

7.  Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.

Authors:  J McAuley; K M Boyer; D Patel; M Mets; C Swisher; N Roizen; C Wolters; L Stein; M Stein; W Schey
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

8.  Partial sight and blindness in children of the 1970 birth cohort at 10 years of age.

Authors:  S L Stewart-Brown; M N Haslum
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

9.  Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

Authors:  C B Wilson; J S Remington; S Stagno; D W Reynolds
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

10.  Congenital toxoplasmosis: eye manifestations in infants and children.

Authors:  K Vutova; Z Peicheva; A Popova; V Markova; N Mincheva; T Todorov
Journal:  Ann Trop Paediatr       Date:  2002-09
View more
  9 in total

1.  Diagnosing the cause of bilateral paediatric cataracts: comparison of standard testing with a next-generation sequencing approach.

Authors:  M Musleh; G Hall; I C Lloyd; R L Gillespie; S Waller; S Douzgou; J Clayton-Smith; E Kehdi; G C M Black; J Ashworth
Journal:  Eye (Lond)       Date:  2016-06-17       Impact factor: 3.775

2.  Identification of a sporozoite-specific antigen from Toxoplasma gondii.

Authors:  Dolores Hill; Cathleen Coss; J P Dubey; Kristen Wroblewski; Mari Sautter; Tiffany Hosten; Claudia Muñoz-Zanzi; Ernest Mui; Shawn Withers; Kenneth Boyer; Gretchen Hermes; Jessica Coyne; Frank Jagdis; Andrew Burnett; Patrick McLeod; Holmes Morton; Donna Robinson; Rima McLeod
Journal:  J Parasitol       Date:  2011-03-03       Impact factor: 1.276

3.  Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.

Authors:  Kenneth Boyer; Dolores Hill; Ernest Mui; Kristen Wroblewski; Theodore Karrison; J P Dubey; Mari Sautter; A Gwendolyn Noble; Shawn Withers; Charles Swisher; Peter Heydemann; Tiffany Hosten; Jane Babiarz; Daniel Lee; Paul Meier; Rima McLeod
Journal:  Clin Infect Dis       Date:  2011-10-21       Impact factor: 9.079

4.  Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis Study.

Authors:  A Gwendolyn Noble; Paul Latkany; Jaroslaw Kusmierczyk; Marilyn Mets; Peter Rabiah; Kenneth Boyer; Jessica Jalbrzikowski; Kristen Wroblewski; Theodore Karrison; Charles N Swisher; William F Mieler; Paul Meier; Rima McLeod
Journal:  Sci Med (Porto Alegre)       Date:  2010

Review 5.  Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview.

Authors:  Mariangela Soberón Felín; Kanix Wang; Aliya Moreira; Andrew Grose; Karen Leahy; Ying Zhou; Fatima Alibana Clouser; Maryam Siddiqui; Nicole Leong; Perpetua Goodall; Morgan Michalowski; Mahmoud Ismail; Monica Christmas; Stephen Schrantz; Zuleima Caballero; Ximena Norero; Dora Estripeaut; David Ellis; Catalina Raggi; Catherine Castro; Davina Moossazadeh; Margarita Ramirez; Abhinav Pandey; Kevin Ashi; Samantha Dovgin; Ashtyn Dixon; Xuan Li; Ian Begeman; Sharon Heichman; Joseph Lykins; Delba Villalobos-Cerrud; Lorena Fabrega; José Luis Sanchez Montalvo; Connie Mendivil; Mario R Quijada; Silvia Fernández-Pirla; Valli de La Guardia; Digna Wong; Mayrene Ladrón de Guevara; Carlos Flores; Jovanna Borace; Anabel García; Natividad Caballero; Claudia Rengifo-Herrera; Maria Theresa Moreno de Saez; Michael Politis; Kristen Wroblewski; Theodore Karrison; Stephanie Ross; Mimansa Dogra; Vishan Dhamsania; Nicholas Graves; Marci Kirchberg; Kopal Mathur; Ashley Aue; Carlos M Restrepo; Alejandro Llanes; German Guzman; Arturo Rebellon; Kenneth Boyer; Peter Heydemann; A Gwendolyn Noble; Charles Swisher; Peter Rabiah; Shawn Withers; Teri Hull; Chunlei Su; Michael Blair; Paul Latkany; Ernest Mui; Daniel Vitor Vasconcelos-Santos; Alcibiades Villareal; Ambar Perez; Carlos Andrés Naranjo Galvis; Mónica Vargas Montes; Nestor Ivan Cardona Perez; Morgan Ramirez; Cy Chittenden; Edward Wang; Laura Lorena Garcia-López; Juliana Muñoz-Ortiz; Nicolás Rivera-Valdivia; María Cristina Bohorquez-Granados; Gabriela Castaño de-la-Torre; Guillermo Padrieu; Juan David Valencia Hernandez; Daniel Celis-Giraldo; Juan Alejandro Acosta Dávila; Elizabeth Torres; Manuela Mejia Oquendo; José Y Arteaga-Rivera; Dan L Nicolae; Andrey Rzhetsky; Nancy Roizen; Eileen Stillwaggon; Larry Sawers; Francois Peyron; Martine Wallon; Emanuelle Chapey; Pauline Levigne; Carmen Charter; Migdalia De Frias; Jose Montoya; Cindy Press; Raymund Ramirez; Despina Contopoulos-Ioannidis; Yvonne Maldonado; Oliver Liesenfeld; Carlos Gomez; Kelsey Wheeler; Ellen Holfels; David Frim; David McLone; Richard Penn; William Cohen; Samantha Zehar; James McAuley; Denis Limonne; Sandrine Houze; Sylvie Abraham; Raphael Piarroux; Vera Tesic; Kathleen Beavis; Ana Abeleda; Mari Sautter; Bouchra El Mansouri; Adlaoui El Bachir; Fatima Amarir; Kamal El Bissati; Alejandra de-la-Torre; Gabrielle Britton; Jorge Motta; Eduardo Ortega-Barria; Isabel Luz Romero; Paul Meier; Michael Grigg; Jorge Gómez-Marín; Jagannatha Rao Kosagisharaf; Xavier Sáez Llorens; Osvaldo Reyes; Rima McLeod
Journal:  Curr Pediatr Rep       Date:  2022-08-22

6.  The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis.

Authors:  Kallyne K Mimura; Roberto C Tedesco; Katia S Calabrese; Cristiane D Gil; Sonia M Oliani
Journal:  Mol Vis       Date:  2012-06-15       Impact factor: 2.367

Review 7.  Clinical features and treatment of ocular toxoplasmosis.

Authors:  Young-Hoon Park; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2013-08-30       Impact factor: 1.341

8.  Clinical Features and Risk Factors of Patients with Presumed Ocular Toxoplasmosis.

Authors:  Ukamaka Celestina Fuh; Afekhide E Omoti; Malachi E Enock
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar

9.  Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.

Authors:  Huân M Ngô; Ying Zhou; Hernan Lorenzi; Kai Wang; Taek-Kyun Kim; Yong Zhou; Kamal El Bissati; Ernest Mui; Laura Fraczek; Seesandra V Rajagopala; Craig W Roberts; Fiona L Henriquez; Alexandre Montpetit; Jenefer M Blackwell; Sarra E Jamieson; Kelsey Wheeler; Ian J Begeman; Carlos Naranjo-Galvis; Ney Alliey-Rodriguez; Roderick G Davis; Liliana Soroceanu; Charles Cobbs; Dennis A Steindler; Kenneth Boyer; A Gwendolyn Noble; Charles N Swisher; Peter T Heydemann; Peter Rabiah; Shawn Withers; Patricia Soteropoulos; Leroy Hood; Rima McLeod
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.